Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Tolerability of Phenylbutyrate in Inclusion Body Myositis

NCT04421677 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT04421677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04421677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Tolerability of Phenylbutyrate in Inclusion Body Myositis
Lead sponsor
University of Kansas Medical Center
Phase
Phase 1
Overall status
Completed
Start date
August 20, 2020
Completion date
January 20, 2022
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inclusion body myositis, sporadic inclusion body myositis